NSEInvestor Presentation1d ago · 17 Nov 2026, 05:55 pm

Investor Presentation

IIRM Holdings India Limited · IIRM

✦ AI SummaryResults

IIRM Holdings India Limited has informed the Exchange about Investor Presentation for Q2 FY27 (6M- FY 27) with attached presentation available on the company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IIRM Holdings India Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

8447772518_17112026175455_Investor_Presentation_Q2_FY27_SD.pdf

pdf

Download →
View document text
Date: 17/11/2026 BSE Limited, National Stock Exchange of India Limited The Calcutta Stock Exchange Limited 1st Floor, P.J. Towers, Exchange Plaza, Plot No. C/1, G Block, 7, Lyons Range, Dalal Street, Fort, Bandra-Kurla Complex, Dalhousie, Mumbai - 400 001. Bandra (East), Mumbai 400051 Kolkata 700 001 Scrip Code: 526530 Scrip Code: IIRM Scrip Code: 029404 Subject: Investor Presentation – Q2 FY27 (6M- FY 27) Respected Sir/Madam, With reference to above captioned subject, please find attached herewith Investor Presentation – Q2 FY27. (6M- FY 27) This intimation is also being made available on the website of the Company at https://www.iirmholdings.in/investor/other-information-disclosures/. Kindly take the above information on record. Thanking You. Yours faithfully, For IIRM Holdings India Limited Vempala Sri Lakshmi Company Secretary & Compliance Officer M. No. F9950 Your Trusted Partner in Global Insurance Solutions I nv estor P resentati on Q 2- F Y 27 Safe Harbour This presentation has been prepared by and is the sole responsibility of IIRM Holdings India Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate. Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes. TABLE OF CONTENTS Industry Landscape Quarterly and Half Year Highlights Company Overview Business Overview Road Map Industry Landscape Insurance Industry Overview INDIA SRI LANKA MALDIVES KENYA Recovery and High-growth Digital inclusion Health-led scale corporate lines specialist niche tailwinds 12% estimated CAGR 10% estimated CAGR 18% estimated CAGR 15% estimated CAGR Health 44% | Motor 30% market Motor-led | Fire & Engineering Tourism | Property | Marine Motor | Medical | Property share in General Insurance Industry IRDAI consultation paper | current status Recalibrating Economics of Insurance Distribution Regulator’s concerns Broker feedback Consultation read-through IIRM view • Mis-selling and weak customer • Diagnosis is broadly accepted; the • Extensive engagement across • Some moderation from the original outcomes remedy must reflect channel insurers, brokers and other proposals is expected • Insurance penetration and economics stakeholders • Final regulations are still awaited customer base not expanding • Life and non-life, corporate, retail • Industry responses and media • Implementation date remains sufficiently and fintech models play different debate have surfaced the practical uncertain • Distribution costs rising faster than roles nuances • Two plausible effective dates: 1 Jan premium growth • Uniform principles are possible, • Insurer pushback appears broad, 2027 or 1 Apr 2027 • Need for greater transparency, but identical prescriptions are not except among the largest players suitability and accountability • Excessive micro-management may likely to gain share drive opaque or “shadow” • Brokers have also escalated payments representations across key policy • Prefer a measured glide path over forums abrupt structural change • Overall impression: the regulator now has a fuller view of market complexity KEY TAKEAWAY Direction of reform is likely to remain; the key variables are calibration, transition period and implementation date. Non Life India Insurance Industry Q2 FY27 YoY Market Share Segment Wise Q2 FY27 Market Share segment wise Q2 FY26 Marine Marine 2% Engineering Others Fire 2% Others Fire Engin 2e %ering 15% 6% 15% 9% Motor Health 37% Health Motor 38% 36% 36% % Q2 YoY Growth % Q1 YoY Growth 32.22% 33.88% 18.73% 14.53% 13.82% 13.90% 12.43% 8.25% 10.04% 9.68% 3.17% -2.16% Fire Marine Engineering Motor Health Others Total -27.84% -24.57% Quarterly Highlights Consolidated Q2 FY27 financial performance in INR Mn PREMIUM GROWTH Q2 FY27 vs +2% growth in Q2 FY26 REVENUE GROWTH Q2 FY27 vs 24% growth Q2 FY26 EBITDA MARGIN Q2 FY27 300 23% 200 +vs 23% in Q2 FY26 100 67 72 52 52 PAT MARGIN Q2 FY27 Total Income Expenses EBITDA PBT PAT vs 9% in Q2 FY26 Q2 FY27 Q2 FY26 Management Commentary and Q3 Outlook Industry Context and Premium Business Mix and Earnings Resilience Growth ~8% Overall industry growth +9% Q2 FY27 premium growth remains subdued • Industry growth remains moderate at about 8%. • Lower Property premium rates reduced reported premium values and headline growth. • Our Q2 premium growth of 9% is broadly in line with the market. • Reinsurance and Personal Lines remain strong growth drivers. Q3 Stable EBITDA and earnings Outlook and guidance performance • Growth momentum should continue, led by • Improved brokerage yields across most Reinsurance and Personal Lines. business lines have supported profitability, • Improved brokerage yields should support while EBITDA has remained stable. stable earnings. Consolidated H1 FY27 financial performance in INR Mn PREMIUM GROWTH H1 FY27 1600 1,416.4 vs +5.2% growth in H1 FY26 1400 1,276.5 REVENUE GROWTH H1 FY27 1200 1,080.8 11% 977.7 1000 vs 12% growth in H1 FY26 EBITDA MARGIN H1 FY27 400 335.6 298.8 +vs 23% in H1 FY26 170.2 175.7 200 129.8 128.6 PAT MARGIN H1 FY27 0 9% Total Income Expenses EBITDA PBT PAT H1 FY27 H1 FY26 vs 10% in H1 FY26 Portfolio Spread – Geography wise (Premium) Premium Location wise (INR Mn.) GWP mix location wise as on H1 FY27 Maldives Sri Lanka 16113 2% 13,268 120 11,444 15085 4147 12,785 11,141 34.3 4037 75.7 India FY24 FY25 FY26 H1 FY27 India Sri Lanka Maldives Total Portfolio Spread – Line of Business wise(Premium) GWP LOB wise Mix H1 FY27 SBU wise premium mix as on [Showing first 8,000 characters — download PDF for full document]